These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26478210)

  • 1. Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation.
    Perretti M; Leroy X; Bland EJ; Montero-Melendez T
    Trends Pharmacol Sci; 2015 Nov; 36(11):737-755. PubMed ID: 26478210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases.
    Perucci LO; Sugimoto MA; Gomes KB; Dusse LM; Teixeira MM; Sousa LP
    Expert Opin Ther Targets; 2017 Sep; 21(9):879-896. PubMed ID: 28786708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The resolution of inflammation: New mechanisms in patho-physiology open opportunities for pharmacology.
    Perretti M
    Semin Immunol; 2015 May; 27(3):145-8. PubMed ID: 26209504
    [No Abstract]   [Full Text] [Related]  

  • 4. Resolution of inflammation: a new therapeutic frontier.
    Fullerton JN; Gilroy DW
    Nat Rev Drug Discov; 2016 Aug; 15(8):551-67. PubMed ID: 27020098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators.
    Serhan CN
    J Periodontol; 2008 Aug; 79(8 Suppl):1520-6. PubMed ID: 18673006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine-tuning inflammation-resolution programs: focus on atherosclerosis.
    Fredman G; Sadhu S; Rymut N
    Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):117-123. PubMed ID: 27984234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Signaling mechanisms involved in resolution of inflammation].
    Cervantes-Villagrana RD; Cervantes-Villagrana AR; Presno-Bernal JM
    Gac Med Mex; 2014; 150(5):440-9. PubMed ID: 25275846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution.
    Serhan CN
    Histochem Cell Biol; 2004 Oct; 122(4):305-21. PubMed ID: 15322859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-target drugs to address multiple checkpoints in complex inflammatory pathologies: evolutionary cues for novel "first-in-class" anti-inflammatory drug candidates: a reviewer's perspective.
    Mathew G; Unnikrishnan MK
    Inflamm Res; 2015 Oct; 64(10):747-52. PubMed ID: 26186905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formyl peptide receptor type 2 agonists to kick-start resolution pharmacology.
    Perretti M; Godson C
    Br J Pharmacol; 2020 Oct; 177(20):4595-4600. PubMed ID: 32954491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediators of the Resolution of the Inflammatory Response.
    Sugimoto MA; Vago JP; Perretti M; Teixeira MM
    Trends Immunol; 2019 Mar; 40(3):212-227. PubMed ID: 30772190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What the surgeon needs to know about basic new concepts of inflammation and their therapeutic consequences: sanitation of inflammation is not a passive but rather an active process regulated by lipid mediators].
    Gardemann A; Meyer F; Braun-Dullaeus R
    Zentralbl Chir; 2013 Jun; 138(3):322-30. PubMed ID: 23807584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases.
    de Gaetano M
    Semin Immunol; 2023 Jan; 65():101699. PubMed ID: 36428172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potentials of selected therapeutic targets for inflammation: a snapshot.
    Nayadu S; Kaur G; Gudi G; Addepalli V
    Recent Pat Inflamm Allergy Drug Discov; 2012 May; 6(2):137-46. PubMed ID: 22432894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
    Serhan CN
    Pharmacol Ther; 2005 Jan; 105(1):7-21. PubMed ID: 15626453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resolution of inflammation--pharmacological aspects].
    Leon MM; Jaba IM; Cozma CD; Albu E; Bahnea R; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):470-6. PubMed ID: 21870743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
    Serhan CN
    Annu Rev Immunol; 2007; 25():101-37. PubMed ID: 17090225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
    McGeer PL; Rogers J; McGeer EG
    J Alzheimers Dis; 2016 Oct; 54(3):853-857. PubMed ID: 27716676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of inflammation: targeting GPCRs that interact with lipids and peptides.
    Cash JL; Norling LV; Perretti M
    Drug Discov Today; 2014 Aug; 19(8):1186-92. PubMed ID: 24993159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the resolution of inflammation.
    Gilroy D; De Maeyer R
    Semin Immunol; 2015 May; 27(3):161-8. PubMed ID: 26037968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.